Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats (original) (raw)
Accumulation of Amyloid β Protein in Transgenic Mice
Mitsuyasu Kanai
Neurobiology of Aging, 1998
View PDFchevron_right
Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
Amanda Kiliaan
Neurobiology of Disease, 2006
View PDFchevron_right
Beta-Amyloid Toxicity in Embryonic Rat Astrocytes
Jeremy Montague
Neurochemical Research, 2007
View PDFchevron_right
Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain
Shelly Whelan
Neuroscience, 2000
View PDFchevron_right
Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
Tobias Welt
Acta Neuropathologica Communications, 2015
View PDFchevron_right
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice
Qing X Yang
Journal of Magnetic Resonance Imaging, 2009
View PDFchevron_right
Seed-dependent templating of murine AA amyloidosis
Katarzyna Lundmark
Amyloid, 2017
View PDFchevron_right
Mechanism of cellular production and in vivo seeding effects of hexameric β-amyloid assemblies
Pascal Kienlen-Campard
bioRxiv (Cold Spring Harbor Laboratory), 2020
View PDFchevron_right
P1-044: Intraneuronal amyloid-β does not cause reduced brain volumes in novel mouse models with Austrian Alzheimer mutation
Christine Van Broeckhoven
Alzheimer's & Dementia, 2008
View PDFchevron_right
Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically
James Lah
BMC Neuroscience, 2008
View PDFchevron_right
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
John Kemp
PLoS ONE, 2009
View PDFchevron_right
Alzheimer's disease: Molecular genetics and transgenic animal models
Ronnie Folkesson
Behavioural Brain Research, 1993
View PDFchevron_right
Intracellular Generation and Accumulation of Amyloid beta -Peptide Terminating at Amino Acid 42
Uwe Leimer
Journal of Biological Chemistry, 1997
View PDFchevron_right
Transgenic Mice as a Model of Pre-Clinical Alzheimers Disease
A.C. Cuello
Current Alzheimer Research, 2011
View PDFchevron_right
Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies
Pascal Kienlen-Campard
Molecular Neurobiology, 2021
View PDFchevron_right
Aβ peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer’s disease pathogenesis
Bernd Sommer
Molecular Psychiatry, 1998
View PDFchevron_right
A transgenic rat expressing human APP with the Swedish Alzheimer’s disease mutation
elena popova
Biochemical and Biophysical Research Communications, 2007
View PDFchevron_right
Structure and function of amyloid in Alzheimer's disease
Nibaldo Inestrosa
Progress in Neurobiology, 2004
View PDFchevron_right
Adaptation to Stressors by Systemic Protein Amyloidogenesis
Caroline Gardiner
Developmental Cell, 2016
View PDFchevron_right
In vivo characterization of the early states of the amyloid-beta network
Reisa Sperling
Brain, 2013
View PDFchevron_right
Early-onset Formation of Parenchymal Plaque Amyloid Abrogates Cerebral Microvascular Amyloid Accumulation in Transgenic Mice
William Van Nostrand
Journal of Biological Chemistry, 2014
View PDFchevron_right
Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
emeline keller
PLOS ONE, 2013
View PDFchevron_right
Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Dominic Walsh
Experimental Neurology, 2010
View PDFchevron_right
Amyloid β precursor protein as a molecular target for amyloid β–induced neuronal degeneration in Alzheimer's disease
Anahi Bignante
Neurobiology of Aging, 2013
View PDFchevron_right
Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission
Katarzyna Lundmark
Cold Spring Harbor Perspectives in Medicine, 2017
View PDFchevron_right
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Agneta Nordberg
Brain, 2006
View PDFchevron_right
The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models
Pascal Kienlen-Campard
Experimental Gerontology, 2000
View PDFchevron_right
Functional Amyloids and their Possible Influence on Alzheimer Disease
Hamza Arshad
Discoveries
View PDFchevron_right
Monitoring of β-Amyloid Dynamics after Human Traumatic Brain Injury
Lars Hillered
Journal of Neurotrauma, 2014
View PDFchevron_right
Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum
Alan Harvey
PLoS ONE, 2013
View PDFchevron_right
A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy
William Van Nostrand
The American Journal of Pathology, 2018
View PDFchevron_right
Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison
Tobias Welt
NeuroImage, 2016
View PDFchevron_right
Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types
Rohanah Hussain
Biochemical Journal, 2000
View PDFchevron_right
Cerebral Amyloid Angiopathy and Parenchymal Amyloid Deposition in Transgenic Mice Expressing the Danish Mutant Form of Human BRI 2
Leticia Miravalle
Brain Pathology, 2009
View PDFchevron_right
Our challenges in an extraordinary case of al amyloidosis
Fortune Journals
View PDFchevron_right